Dr. Chatterjee is a med-peds trained primary care and addiction medicine physician at several shelter-based clinics through Boston Health Care for the Homeless Program. His areas of clinical and research interest include innovative treatment models for opioid use disorder in marginalized populations, and interventions on social determinants of health, such as food insecurity. He has an additional interest in racism and health care, particularly its manifestations in medical education and training.
Diversity, Equity, Inclusion and Accessibility
My Diversity/Equity Inclusion work has taken several forms:
I have worked to explore the role of racism in health professions admissions and in medical education. I and my colleagues have written several papers on bias due to race, gender, and other factors during the interview process to medical school and other health profession programs. While at Harvard Medical School, I was the faculty advisor for the Racial Justice Coalition and in that role, worked to expand and improve the curriculum with regard to its discussion of racism in health care. As part of that role, I have mentored several students in writing papers describing these efforts.
Secondly, I have worked to explore the role of racism in the conceptualization and treatment of addiction in the United States. In my role on the Healing Communities Study, I helped found the Racial Equity and Social Justice committee, which works to improve efforts to incorporate intentional efforts to promote equity in addiction treatment. We describe our work in a paper in the American Journal of Public Health, but the racial equity work we are undertaking is ongoing.
I serve in several committee roles at BMC and in national organizations. I serve on the Boston University Medical Group (BUMG) Diversity and Inclusion Advisory Council, as well as the Section of General Internal Medicine's Anti-Racism committee. I also serve on AMERSA's Diversity Committee. In that role, I am leading a subcommittee that is developing a bibliography of papers on other resources examining the role of racism in addiction treatment.
Member
Boston University
Evans Center for Interdisciplinary Biomedical Research
Faculty
Boston University Chobanian & Avedisian School of Medicine
Medicine
Clinical Addiction Research and Education Unit
This tab shows grant data from BMC Sponsored Research. It includes:
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
This tab shows grant data from BU Sponsored Research. It includes:
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
This tab shows grant data that did not automatically get imported into Profiles
from BU or BMC sources.
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
This tab shows grant data from the Boston VA. We are only showing grant title, and only for people in the role of PI.
Rapid measurement of novel harm reduction housing on HIV risk, treatment uptake, drug use and supply05/01/2023 - 04/30/2026 (Subcontract PI)
PI:
Avik Chatterjee, MD, MPHBrandeis University NIH NIDA
Bloomberg American Health Initiative09/01/2024 - 06/30/2025 (PI)
Johns Hopkins University
Together We Rize 5th Anniversary Grant Program: Shelter Harm Reduction12/02/2022 - 10/31/2024 (PI)
RIZE Massachusetts
Evaluation of the Community Care in Reach(R) Mobile Addiction Initiative for Youth and Young Adults (YYA)12/01/2021 - 11/30/2023 (PI)
Massachusetts General Hospital
|
Yr
|
Title
|
Project-Sub Proj
|
Pubs
|
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
login
to make corrections and additions.
-
-
Johnson L, Chatterjee A. The Expiration of the Addiction Medicine Practice-Based Pathways Will Increase the Specialty's Challenges. J Stud Alcohol Drugs. 2025 Nov; 86(6):997-999. PMID: 40748286
-
Harris MTH, Hall M, Ellison S, Holloway J, Bridden C, Bagley SM, Bullard M, Chassler D, Chatterjee A, Dasgupta A, Drainoni ML, Gruss DE, Jadovich E, Katz R, Mayotte C, Neufeld JL, Oga E, Glasgow L. Tailored strategies to reduce opioid overdose deaths for pregnant and postpartum women: Examples and lessons learned from the HEALing Communities Study. J Subst Use Addict Treat. 2025 Oct; 177:209766.View Related Profiles. PMID: 40752834; DOI: 10.1016/j.josat.2025.209766;
-
Levengood TW, Shaw LC, Zang X, Schackman BR, Walley AY, Urquhart C, Green TC, Chatterjee A, Marshall BDL, Morgan JR. A geospatial analysis of naloxone distribution patterns in the Massachusetts overdose education and naloxone distribution program (MA OEND). Drug Alcohol Depend. 2025 Sep 01; 274:112783.View Related Profiles. PMID: 40683013; PMCID: PMC12439111; DOI: 10.1016/j.drugalcdep.2025.112783;
-
Green TC, Silcox J, Zaragoza S, Summers C, Rapisarda S, Kosakowski S, Rolles A, Chatterjee A, Walley A, Komaromy M, Case P. Study Protocol on Rapid Measurement of Novel Harm Reduction Housing on HIV Risk, Treatment Uptake, Drug Use, and Supply. Subst Use Addctn J. 2025 Oct; 46(4):1058-1063.View Related Profiles. PMID: 40552912; DOI: 10.1177/29767342251341706;
-
Zwick H, O'Dea R, Barocas JA, Flam-Ross JM, Chatterjee A, Walley AY, Harris RA, Schackman BR, White LF, Chrysanthopoulou SA, Assoumou SA, Murphy SM, Morgan JR, Baptiste D, Carroll M, Linas BP. Health and Economic Outcomes of Addressing Encampments of Individuals Using Opioids. JAMA Netw Open. 2025 Jun 02; 8(6):e2517095.View Related Profiles. PMID: 40577017; PMCID: PMC12205401; DOI: 10.1001/jamanetworkopen.2025.17095;
-
Gibson EB, Glasgow L, Nouvong M, McGladrey M, Freedman D, Chassler D, Vickers-Smith R, D'Onfro M, Goddard-Eckrich DA, Hunt T, Chatterjee A, Holloway J, Fain K, Cruz RS, Martinez LS. Implementing and documenting cultural adaption of evidence-based practice strategies to reduce opioid overdose deaths: examples and lessons from the HEALing communities study. Discov Public Health. 2025; 22(1):296. PMID: 40433450; PMCID: PMC12104109; DOI: 10.1186/s12982-025-00696-2;
-
Renehan CM, Wiggins M, Puppala R, Chatterjee A, Obando A, Coleman KR, Raj A, Schmill DM, Flynn D, Bagley SM. A Scoping Review of Youth Overdose Prevention Interventions. J Addict Med. 2025 May 09.View Related Profiles. PMID: 40344021
-
Noyes E, Hausman E, Yeo EJ, Bain PA, Bannister M, Lopez IB, Rajakumar B, Wang G, Chatterjee A. Harm reduction interventions for AYA who use opioids: A scoping review. Drug Alcohol Depend. 2025 Jul 01; 272:112677. PMID: 40339383
-
Showing 10 of 72 results.
Show More
-
Johnson NL, Beaugard CA, Heredia-Perez D, So-Armah K, Reason P, Yule AM, Lee CS, Chapman SE, Chatterjee A, McClay C, Weeden T, Becerril C, Thomas D, Komaromy M. Embracing anti-racism: Co-creating recommendations with Black people for how addiction treatment needs to change. Soc Sci Med. 2025 Jan; 364:117433.View Related Profiles. PMID: 39615095
-
Zang X, Skinner A, Li Z, Shaw LC, Behrends CN, Chatterjee A, Jalali A, Jordan AE, Morgan JR, Nolen S, Schackman BR, Marshall BDL, Walley AY. Improving racial/ethnic health equity and naloxone access among people at risk for opioid overdose: A simulation modeling analysis of community-based naloxone distribution strategies in Massachusetts, United States. Addiction. 2025 Feb; 120(2):316-326.View Related Profiles. PMID: 39450522; PMCID: PMC11707306; DOI: 10.1111/add.16691;
-
-
Beaugard CA, Johnson NL, Heredia-Perez D, Chapman SE, Chatterjee A, Lee CS, McClay C, Reason P, Thomas D, Weeden T, Yule AM, So-Armah K, Komaromy M. The Effect of Racial Concordance for Black Patients in Addiction Treatment: A Scoping Review of the Literature. Subst Use Addctn J. 2025 Jan; 46(1):103-111.View Related Profiles. PMID: 39394669
-
-
Dunleavy S, Douchee J, Liu T, Johnson NL, Komaromy M, Chatterjee A. Racism, not race: Quantitative analysis of the use of race and racism in the addiction literature. Soc Sci Med. 2024 Nov; 360:117325.View Related Profiles. PMID: 39293285
-
Castry M, Tin Y, Feder NM, Lewis N, Chatterjee A, Rudorf M, Samet JH, Beers D, Medley B, Gilbert L, Linas BP, Barocas JA. An economic analysis of the cost of mobile units for harm reduction, naloxone distribution, and medications for opioid use disorder. J Subst Use Addict Treat. 2024 Dec; 167:209517.View Related Profiles. PMID: 39299504; PMCID: PMC11527578; DOI: 10.1016/j.josat.2024.209517;
-
Ascunce Gonzalez K, Swartz N, Linares MA, Gelpí-Acosta C, Chatterjee A. Latine perspectives on the impact of family, perceptions of medication, health systems, incarceration, and housing on accessing opioid agonist therapy: A thematic analysis. J Subst Use Addict Treat. 2024 Dec; 167:209491. PMID: 39179210
-
-
-
Pinkhover A, Celata K, Baker T, Chatterjee A, Lunze K. Mobile addiction treatment and harm reduction services as tools to address health inequities: a community case study of the Brockton Neighborhood Health Center mobile unit. Front Public Health. 2024; 12:1407522.View Related Profiles. PMID: 38957203; PMCID: PMC11217472; DOI: 10.3389/fpubh.2024.1407522;
-
-
Mayer M, Mejia Urieta Y, Martinez LS, Komaromy M, Hughes U, Chatterjee A. Encampment Clearings And Transitional Housing: A Qualitative Analysis Of Resident Perspectives. Health Aff (Millwood). 2024 Feb; 43(2):218-225.View Related Profiles. PMID: 38315933
-
Chatterjee A, Baker T, Rudorf M, Walt G, Stotz C, Martin A, Kinnard EN, McAlearney AS, Bosak J, Medley B, Pinkhover A, Taylor JL, Samet JH, Lunze K. Mobile treatment for opioid use disorder: Implementation of community-based, same-day medication access interventions. J Subst Use Addict Treat. 2024 Apr; 159:209272.View Related Profiles. PMID: 38128649; PMCID: PMC10947870; DOI: 10.1016/j.josat.2023.209272;
-
Chatterjee A, Obando A. LGBTQ+ Youth Experiencing Homelessness: Health Impacts and a Call to Action. Pediatrics. 2023 Dec 01; 152(6). PMID: 37981854; DOI: 10.1542/peds.2023-063808;
-
Zang X, Walley AY, Chatterjee A, Kimmel SD, Morgan JR, Murphy SM, Linas BP, Nolen S, Reilly B, Urquhart C, Schackman BR, Marshall BDL. Changes to opioid overdose deaths and community naloxone access among Black, Hispanic and White people from 2016 to 2021 with the onset of the COVID-19 pandemic: An interrupted time-series analysis in Massachusetts, USA. Addiction. 2023 Dec; 118(12):2413-2423.View Related Profiles. PMID: 37640687; PMCID: PMC10986189; DOI: 10.1111/add.16324;
-
Chatterjee A, Yan S, Lambert A, Morgan JR, Green TC, Jeng PJ, Jalali A, Xuan Z, Krieger M, Marshall BDL, Walley AY, Murphy SM. Comparison of a national commercial pharmacy naloxone data source to state and city pharmacy naloxone data sources-Rhode Island, Massachusetts, and New York City, 2013-2019. Health Serv Res. 2023 Oct; 58(5):1141-1150.View Related Profiles. PMID: 37408299; PMCID: PMC10480090; DOI: 10.1111/1475-6773.14200;
-
Swartz N, Odayappan S, Chatterjee A, Cutler D. Impact of Medicaid expansion on inclusion of medications for opioid use disorder in homeless adults' treatment plans. J Subst Use Addict Treat. 2023 Sep; 152:209059. PMID: 37207834
-
Dang N, Khunte M, Zhong A, Chatterjee A. Naloxone Online Information Exceeds the Recommended Reading Level for Patient Education Materials. J Stud Alcohol Drugs. 2023 Sep; 84(5):680-683. PMID: 37096779; DOI: 10.15288/jsad.22-00343;
-
Chatterjee A, Bannister M, Hill LG, Davis CS. Prescribing Syringes to People Who Inject Drugs: Advancing Harm Reduction in Primary Care. J Gen Intern Med. 2023 Jun; 38(8):1980-1983. PMID: 37020124; PMCID: PMC10271981; DOI: 10.1007/s11606-023-08183-7;
-
Chatterjee A, Weitz M, Savinkina A, Macmadu A, Madushani RWMA, Potee RA, Ryan D, Murphy SM, Walley AY, Linas BP. Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts. JAMA Netw Open. 2023 Apr 03; 6(4):e237036.View Related Profiles. PMID: 37058306; PMCID: PMC10105308; DOI: 10.1001/jamanetworkopen.2023.7036;
-
Chatterjee A, Dunleavy S, Gonzalez T, Benson J, Henault L, MacIntosh A, Goodell K, Witzburg R, Paasche-Orlow M. Health professions school applicant experiences of discrimination during interviews. Med Teach. 2023 May; 45(5):532-541.View Related Profiles. PMID: 36369780
-
Nolen S, Zang X, Chatterjee A, Behrends CN, Green TC, Linas BP, Morgan JR, Murphy SM, Walley AY, Schackman BR, Marshall BDL. Evaluating equity in community-based naloxone access among racial/ethnic groups in Massachusetts. Drug Alcohol Depend. 2022 Dec 01; 241:109668.View Related Profiles. PMID: 36309001; PMCID: PMC9833886; DOI: 10.1016/j.drugalcdep.2022.109668;
-
Morgan JR, Freibott CE, Jalali A, Jeng PJ, Walley AY, Chatterjee A, Green TC, Nolan ML, Linas BP, Marshall BDL, Murphy SM. The role of increasing pharmacy and community distributed naloxone in the opioid overdose epidemic in Massachusetts, Rhode Island, and New York City. Drug Alcohol Depend Rep. 2022 Sep; 4.View Related Profiles. PMID: 36337350; PMCID: PMC9631422; DOI: 10.1016/j.dadr.2022.100083;
-
Adams JW, Savinkina A, Fox A, Behrends CN, Madushani RWMA, Wang J, Chatterjee A, Walley AY, Barocas JA, Linas BP. Modeling the cost-effectiveness and impact on fatal overdose and initiation of buprenorphine-naloxone treatment at syringe service programs. Addiction. 2022 Oct; 117(10):2635-2648.View Related Profiles. PMID: 35315148; PMCID: PMC9951221; DOI: 10.1111/add.15883;
-
Swartz N, Adnan T, Peréa F, Baggett TP, Chatterjee A. "Sick and tired of being sick and tired": Exploring initiation of medications for opioid use disorder among people experiencing homelessness. J Subst Abuse Treat. 2022 Jul; 138:108752. PMID: 35277306
-
Noyes EA, Dunleavy S, Mail V, Plakas I, Keyes S, Gaeta JM, Obando A, Paci E, Lent C, Regis C, Taveras EM, Yule AM, Chatterjee A. Awareness, Utilization, and Preferences of Harm Reduction Interventions among Street-Involved Young Adults in Boston. Subst Use Misuse. 2022; 57(5):827-832.View Related Profiles. PMID: 35195488; PMCID: PMC10372698; DOI: 10.1080/10826084.2022.2040031;
-
Chatterjee A, Glasgow L, Bullard M, Sabir M, Hamilton G, Chassler D, Stevens-Watkins DJ, Goddard-Eckrich D, Rodgers E, Chaya J, Rodriguez S, Gutnick DN, Oga EA, Salsberry P, Martinez LS. Placing Racial Equity at the Center of Substance Use Research: Lessons From the HEALing Communities Study. Am J Public Health. 2022 02; 112(2):204-208. PMID: 35080947; PMCID: PMC8802575; DOI: 10.2105/AJPH.2021.306572;
-
Lee M, Adnan T, Gilbert H, Obando A, Chatterjee A. Exploring Access and Utilization of Early Intervention Services Among Families Experiencing Homelessness: A Qualitative Study. J Health Care Poor Underserved. 2022; 33(4):1865-1878. PMID: 36341667
-
Nolen S, Zang X, Chatterjee A, Behrends CN, Green TC, Kumar A, Linas BP, Morgan JR, Murphy SM, Walley AY, Yan S, Schackman BR, Marshall BDL. Community-based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode Island. Addiction. 2022 May; 117(5):1372-1381.View Related Profiles. PMID: 34825427; PMCID: PMC8983544; DOI: 10.1111/add.15759;
-
Sandoval RS, Dunleavy S, Afolabi T, Said JT, Connor J, Hossain A, Kassamali B, Kienka T, Srinivasan M, Cheng A, Ölveczky D, Chatterjee A. Equity in medical education: Addressing microaggressions and discrimination on the wards. Med Teach. 2022 May; 44(5):551-558. PMID: 34860635
-
Chatterjee A, Yan S, Xuan Z, Waye KM, Lambert AM, Green TC, Stopka TJ, Pollini RA, Morgan JR, Walley AY. Broadening access to naloxone: Community predictors of standing order naloxone distribution in Massachusetts. Drug Alcohol Depend. 2022 01 01; 230:109190.View Related Profiles. PMID: 34864356; PMCID: PMC8714703; DOI: 10.1016/j.drugalcdep.2021.109190;
-
-
Afolabi T, Borowsky HM, Cordero DM, Paul DW, Said JT, Sandoval RS, Davis D, Ölveczky D, Chatterjee A. Student-Led Efforts to Advance Anti-Racist Medical Education. Acad Med. 2021 06 01; 96(6):802-807. PMID: 33711839
-
Morgan JR, Walley AY, Murphy SM, Chatterjee A, Hadland SE, Barocas J, Linas BP, Assoumou SA. Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort. Drug Alcohol Depend. 2021 08 01; 225:108764.View Related Profiles. PMID: 34051547; PMCID: PMC8488795; DOI: 10.1016/j.drugalcdep.2021.108764;
-
McLaughlin MF, Li R, Carrero ND, Bain PA, Chatterjee A. Opioid use disorder treatment for people experiencing homelessness: A scoping review. Drug Alcohol Depend. 2021 07 01; 224:108717. PMID: 33985863; PMCID: PMC9758007; DOI: 10.1016/j.drugalcdep.2021.108717;
-
Noyes E, Yeo E, Yerton M, Plakas I, Keyes S, Obando A, Gaeta JM, Taveras EM, Chatterjee A. Harm Reduction for Adolescents and Young Adults During the COVID-19 Pandemic: A Case Study of Community Care in Reach. Public Health Rep. 2021 05; 136(3):301-308.View Related Profiles. PMID: 33673755; PMCID: PMC8580390; DOI: 10.1177/0033354921999396;
-
Linas BP, Savinkina A, Madushani RWMA, Wang J, Eftekhari Yazdi G, Chatterjee A, Walley AY, Morgan JR, Epstein RL, Assoumou SA, Murphy SM, Schackman BR, Chrysanthopoulou SA, White LF, Barocas JA. Projected Estimates of Opioid Mortality After Community-Level Interventions. JAMA Netw Open. 2021 02 01; 4(2):e2037259.View Related Profiles. PMID: 33587136; PMCID: PMC7885041; DOI: 10.1001/jamanetworkopen.2020.37259;
-
-
Berkowitz SA, Cené CW, Chatterjee A. Covid-19 and Health Equity - Time to Think Big. N Engl J Med. 2020 Sep 17; 383(12):e76. PMID: 32706955
-
Sandoval RS, Afolabi T, Said J, Dunleavy S, Chatterjee A, Ölveczky D. Building a Tool Kit for Medical and Dental Students: Addressing Microaggressions and Discrimination on the Wards. MedEdPORTAL. 2020 04 03; 16:10893. PMID: 32352030; PMCID: PMC7187912; DOI: 10.15766/mep_2374-8265.10893;
-
Chatterjee A. Capsule Commentary on Saha et al., Impact of Physician Race on Patient Decision-making and Ratings of Physicians. J Gen Intern Med. 2020 04; 35(4):1361. PMID: 32076991; PMCID: PMC7174492; DOI: 10.1007/s11606-020-05738-w;
-
Chatterjee A, Greif C, Witzburg R, Henault L, Goodell K, Paasche-Orlow MK. US Medical School Applicant Experiences of Bias on the Interview Trail. J Health Care Poor Underserved. 2020; 31(1):185-200.View Related Profiles. PMID: 32037326
-
Chatterjee A, Lopez D, Ramkellawan S, Brown R, Smith K, Gaeta JM, Baggett TP. "That's what we call the cocktail": Non-Opioid medication and supplement misuse among opioid users. Subst Abus. 2021; 42(2):175-182.View Related Profiles. PMID: 31638874
-
Chatterjee A. Overdose, Out Front. Ann Intern Med. 2019 10 15; 171(8):591-592. PMID: 31610572
-
Fozouni L, Buchheit B, Walley AY, Testa M, Chatterjee A. Public restrooms and the opioid epidemic. Subst Abus. 2020; 41(4):432-436.View Related Profiles. PMID: 31368865
-
Pinto Taylor E, Mulenos A, Chatterjee A, Talwalkar JS. Partnering With Interpreter Services: Standardized Patient Cases to Improve Communication With Limited English Proficiency Patients. MedEdPORTAL. 2019 05 20; 15:10826. PMID: 31161138; PMCID: PMC6543860; DOI: 10.15766/mep_2374-8265.10826;
-
Chatterjee A, Larochelle MR, Xuan Z, Wang N, Bernson D, Silverstein M, Hadland SE, Land T, Samet JH, Walley AY, Bagley SM. Non-fatal opioid-related overdoses among adolescents in Massachusetts 2012-2014. Drug Alcohol Depend. 2019 01 01; 194:28-31.View Related Profiles. PMID: 30391835; PMCID: PMC6312455; DOI: 10.1016/j.drugalcdep.2018.09.020;
-
Chatterjee A, Thompson JW, Svensson K, Tamayo Y Ortiz M, Wright R, Wright R, Tellez-Rojo M, Baccarelli A, Cantoral A, Schnaas L, Oken E. Maternal antenatal stress has little impact on child sleep: results from a prebirth cohort in Mexico City. Sleep Health. 2018 10; 4(5):397-404. PMID: 30241653; PMCID: PMC6152833; DOI: 10.1016/j.sleh.2018.07.013;
-
Chatterjee A, Yu EJ, Tishberg L. Exploring opioid use disorder, its impact, and treatment among individuals experiencing homelessness as part of a family. Drug Alcohol Depend. 2018 07 01; 188:161-168. PMID: 29778009
-
Chatterjee A, Kotler D, Kuperman M, McIntosh L, Pendleton C, Chatterjee A. Addressing a Gender Identity Crisis in Medicine. J Grad Med Educ. 2018 Feb; 10(1):8-10. PMID: 29467966; PMCID: PMC5821018; DOI: 10.4300/JGME-D-17-00572.1;
-
Brown R, Chatterjee A. Dietary Inadequacies Among US Homeless Families: An Enduring Problem. J Health Care Poor Underserved. 2018; 29(4):1188-1208. PMID: 30449741; DOI: 10.1353/hpu.2018.0090;
-
Chatterjee A, Brown R, Block JP. "Feastworthy is Something That Gives Us Our Dignity Back:" Feasibility of A Delivered Prepared Meal Program for Families in Motel-Shelters. J Health Care Poor Underserved. 2018; 29(4):1333-1355. PMID: 30449750; DOI: 10.1353/hpu.2018.0099;
-
Chatterjee A. The interview, revisited. Clin Teach. 2018 02; 15(1):76-77. PMID: 28573822
-
Chatterjee A, Obando A, Strickland E, Nestler A, Harrington-Levey R, Williams T, LaCoursiere-Zucchero T. Shelter-Based Opioid Treatment: Increasing Access to Addiction Treatment in a Family Shelter. Am J Public Health. 2017 07; 107(7):1092-1094. PMID: 28520496; PMCID: PMC5463216; DOI: 10.2105/AJPH.2017.303786;
-
Chatterjee A, So M, Dunleavy S, Oken E. Quality Health Care for Homeless Children: Achieving the AAP Recommendations for Care of Homeless Children and Youth. J Health Care Poor Underserved. 2017; 28(4):1376-1392. PMID: 29176102; PMCID: PMC6487635; DOI: 10.1353/hpu.2017.0121;
-
Seward MW, Block JP, Chatterjee A. A Traffic-Light Label Intervention and Dietary Choices in College Cafeterias. Am J Public Health. 2016 10; 106(10):1808-14. PMID: 27552277; PMCID: PMC5024366; DOI: 10.2105/AJPH.2016.303301;
-
Chatterjee A, Daftary G, Campbell M, Gatison L, Day L, Ramsey K, Goldman R, Gillman MW. "Can't We Just Have Some Sazón?" Student, Family, and Staff Perspectives on a New School Food Program at a Boston High School. J Sch Health. 2016 Apr; 86(4):273-80. PMID: 26930239
-
Chatterjee A, Daftary G, Gatison L, Gillman MW. Lessons Learned From a Partnership to Evaluate a School Food Program. Prog Community Health Partnersh. 2016; 10(4):577-584. PMID: 28569683; DOI: 10.1353/cpr.2016.0066;
-
Chatterjee A, Gillman MW, Wong MD. Chaos, Hubbub, and Order Scale and Health Risk Behaviors in Adolescents in Los Angeles. J Pediatr. 2015 Dec; 167(6):1415-21. PMID: 26394824; PMCID: PMC6023620; DOI: 10.1016/j.jpeds.2015.08.043;
-
-
Muth ND, Chatterjee A, Williams D, Cross A, Flower K. Making an IMPACT: effect of a school-based pilot intervention. N C Med J. 2008 Nov-Dec; 69(6):432-40. PMID: 19256179
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.
| Year | Publications |
|---|
| 2008 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 10 |
| 2022 | 8 |
| 2023 | 8 |
| 2024 | 13 |
| 2025 | 10 |